- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 12.49M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $579.35K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $530.54K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $24.36M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $22.25M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $26.84M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $24.67M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $668.36K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $575K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.08M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $2.88M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 12.44M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $5.49K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $6.78K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$13.65M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$11.98M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Net Income | Q1 2024 · Mar 31, 2023 | −$1.67M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $536.8K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $249.4K |
| Revenue | Q1 2024 · Mar 31, 2023 | $786.2K |